Convalescent plasma reduces hospitalization risk in COVID-19 - Healio

Convalescent plasma, when administered within 9 days of symptom onset in patients with COVID-19, may reduce the risk for hospitalization, according to data published in The New England Journal of Medicine. “While everyone was focused on treating people …

Convalescent plasma, when administered within 9 days of symptom onset in patients with COVID-19, may reduce the risk for hospitalization, according to data published in The New England Journal of Med… [+3530 chars]

full article...